Feasibility Archives | Page 3 of 4

Nov20 0

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or motor neuron disease (MND), is a fatal disease of the nervous system, characterized by progressive muscle weakness resulting in paralysis. Symptoms include stiff muscles, muscle twitching, and gradually worsening weakness due to muscles decreasing in size. In ALS, moton neurons controlling the voluntary muscles, […]

Nov06 1

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum. Globally, colorectal cancer is the third most common type of cancer in both men and women making up about 10% of all cases. Currently, there is a significant focus on the development of drugs […]

Oct23 0

The Gastrointestinal (GI) drugs market is a potentially huge market with many different indications, drug types, and treatment regimens. Transparency Market Research and PRNewswire reports predict the global GI drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. While it was worth USD 46.5 Billion in 2016, […]

Oct09 1

Alopecia is a condition in which hairs are lost from some or all areas of the body. In fact, alopecia areata is also known as spot baldness for this reason. Most commonly, patients have bald spots on their scalps about the size of a coin. There are three (3) well-known types of Alopecia Alopecia areata […]

Sep11 0

Acute vestibulopathy is characterized by an acute or subacute onset of vertigo, dizziness, or imbalance with or without ocular motor, sensory, postural or autonomic symptoms, and signs, and can last for seconds to up to several days. What is Acute Unilateral Vestibulopathy? Normal vestibular end organs generate an equal resting-firing frequency of the axons, which […]

Jul17 4

Identification and selection of clinical trial sites and clinical investigators remain one of the first and most crucial decisions that clinical trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site/investigator identification on clinical trial successes time […]

Mar20 3

Trial managers worldwide have been focusing on specific regions for placing their clinical trials. So much so that about 60-70% of clinical trials globally are conducted in the USA and Europe alone. However, this is slated to change or should change, if one consults a recent white paper published by Frost & Sullivan. The white […]

Jan11 0

Investigators, from Brazil who were specialized in Allergy and Immunology segment, were invited to participate in feasibility of a new phase II clinical trial. What’s was the trial about? It’s a phase II – dose selection and confirmatory – clinical trial planned to be conducted in Brazil. What kind of patients were required for this clinical trial? […]

Nov28 0

With patients with ovarian cancer as the target trial population, clinical trial feasibility was performed. The clinical trial sites/investigators, who participated in this feasibility came mainly from India, Russia, the Philippines, Vietnam, Thailand, and South Korea. What are the causes of ovarian cancer? The causes of ovarian cancer are unclear but doctors have identified factors that […]

Nov21 0

Worldwide, breast cancer is the most common invasive cancer in women. Along with lung cancer, breast cancer is the most commonly diagnosed cancer, with 2.09 million cases each in 2018, and Breast cancer affects 1 in 7 (14%) of women worldwide. What is breast cancer? Breast cancer is a cancer that develops from breast tissue. […]

Category: Feasibility

Amyotrophic Lateral Sclerosis – Potentially High Clinical Trial Recruitment With Investigators In Canada

Conducting Colorectal Cancer Clinical Trial? Here Is Why You Should Engage Investigators In Canada

3 Countries For Your Gastro Clinical Trials – Learning From A Duodenal Ulcer Trial Feasibility Report

Alopecia – A Clinical Trial Feasibility in Canada

Acute Unilateral Vestibulopathy – A Clinical Trial Feasibility

How To Save Up to 80% Of Cost And Time In Initiating Clinical Trials

Potential and Challenges With Clinical Trial Sites In Asia & West

Brazil! Phase II Clinical Trial in Allergic Rhinitis

Ovarian Cancer: Clinical Trial Feasibility

Clinical Trial Feasibility: Breast Cancer Studies